BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36931700)

  • 101. A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses.
    Araujo-Ayala F; Dobaño-López C; Valero JG; Nadeu F; Gava F; Faria C; Norlund M; Morin R; Bernes-Lasserre P; Serrat N; Playa-Albinyana H; Giménez R; Campo E; Lagarde JM; López-Guillermo A; Gine E; Colomer D; Bezombes C; Pérez-Galán P
    Leukemia; 2023 Jun; 37(6):1311-1323. PubMed ID: 37031299
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.
    Oliner JD; Pietenpol JA; Thiagalingam S; Gyuris J; Kinzler KW; Vogelstein B
    Nature; 1993 Apr; 362(6423):857-60. PubMed ID: 8479525
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Physical and functional interaction between wild-type p53 and mdm2 proteins.
    Haines DS; Landers JE; Engle LJ; George DL
    Mol Cell Biol; 1994 Feb; 14(2):1171-8. PubMed ID: 8289798
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.
    Chen CY; Oliner JD; Zhan Q; Fornace AJ; Vogelstein B; Kastan MB
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2684-8. PubMed ID: 8146175
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Ajuba: An emerging signal transducer in oncogenesis.
    Jia H; Peng H; Hou Z
    Pharmacol Res; 2020 Jan; 151():104546. PubMed ID: 31740385
    [TBL] [Abstract][Full Text] [Related]  

  • 106. P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation.
    Li XL; Zhou J; Chen ZR; Chng WJ
    World J Gastroenterol; 2015 Jan; 21(1):84-93. PubMed ID: 25574081
    [TBL] [Abstract][Full Text] [Related]  

  • 107. LIM domain-containing protein Ajuba inhibits chemotherapy-induced apoptosis by negatively regulating p53 stability in colorectal cancer cells.
    Xu B; Li Q; Zhang J; Chen F
    Mol Oncol; 2023 Aug; 17(8):1678-1691. PubMed ID: 36931700
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network.
    Jia H; Song L; Cong Q; Wang J; Xu H; Chu Y; Li Q; Zhang Y; Zou X; Zhang C; Chin YE; Zhang X; Li Z; Zhu K; Wang B; Peng H; Hou Z
    Oncogene; 2017 May; 36(19):2655-2666. PubMed ID: 27893714
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa-miR-1184 and releasing AJUBA and inactivating Hippo/YAP signalling.
    Wang X; Chen Y; Liu W; Liu T; Sun D
    J Cell Mol Med; 2020 Sep; 24(17):9908-9924. PubMed ID: 32681581
    [TBL] [Abstract][Full Text] [Related]  

  • 110. LIM protein JUB promotes epithelial-mesenchymal transition in colorectal cancer.
    Liang XH; Zhang GX; Zeng YB; Yang HF; Li WH; Liu QL; Tang YL; He WG; Huang YN; Zhang L; Yu LN; Zeng XC
    Cancer Sci; 2014 Jun; 105(6):660-6. PubMed ID: 24673742
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
    Li H; Fu L; Liu B; Lin X; Dong Q; Wang E
    Gene; 2019 Apr; 693():16-24. PubMed ID: 30690182
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Ajuba transactivates N-cadherin expression in colorectal cancer cells through interaction with Twist.
    Wu Z; Zou X; Xu Y; Zhou F; Kuai R; Li J; Yang D; Chu Y; Peng H
    J Cell Mol Med; 2021 Aug; 25(16):8006-8014. PubMed ID: 34173718
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy.
    Michel M; Kaps L; Maderer A; Galle PR; Moehler M
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064974
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.
    Hernández Borrero LJ; El-Deiry WS
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188556. PubMed ID: 33932560
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The Role of p53 Signaling in Colorectal Cancer.
    Liebl MC; Hofmann TG
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33924934
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review.
    Biller LH; Schrag D
    JAMA; 2021 Feb; 325(7):669-685. PubMed ID: 33591350
    [TBL] [Abstract][Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.